Fosun set to tap HK stock market for US$600m

After shelving its plan because of weak market sentiment, the Shanghai company is now ready to sell shares in its pharmaceutical offshoot

Topic |   Shanghai Fosun Pharmaceutical
READ FULL ARTICLE